» Articles » PMID: 38940836

[Cost Comparison of Conservative Vs. Surgical Treatment of Chronic Lymphedema]

Overview
Specialty General Surgery
Date 2024 Jun 28
PMID 38940836
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lymphedema is primarily treated conservatively using complex physical decongestion treatment (CDT). Lymphovenous anastomosis (LVA), vascularized lymph node transplantation (VLNT) and liposuction are available as surgical treatment methods; however, reimbursement in the diagnosis-related groups (DRG) system is sometimes inadequate or only possible following an individual application. The costs of these relatively new surgical procedures have not yet been set in relation to those of CDT.

Method: The costs of conservative treatment were determined in accordance with the guidelines. The costs for LVA, VLNT and liposuction of the upper and lower extremities were estimated on the basis of the DRG reimbursement per case and the expected reduction in conservative measures according to current knowledge. The annual treatment costs were then compared.

Results: The annual treatment costs of LVA and VLNT are already lower than conservative treatment alone in the second postoperative year. Liposuction reaches this point in the 6th (upper extremity) or 47th postoperative year (lower extremity).

Conclusion: The evidence for the positive effects of lymphatic surgery is still limited; however, it is recognizable that the curative surgical approach can significantly reduce the treatment costs and improve the quality of life of lymphedema patients; however, there is a lack of adequate reflection of the surgical effort in the reimbursement.

Citing Articles

Translation, Cross-Cultural Adaptation and Validation of the Lymphedema Quality of Life Questionnaire (LYMQOL) in German-Speaking Patients with Upper Limb Lymphedema.

Schulz T, Lee Warg M, Heister S, Lidzba K, Ciklatekerlio G, Molter Y Healthcare (Basel). 2024; 12(18).

PMID: 39337222 PMC: 11431024. DOI: 10.3390/healthcare12181881.

References
1.
Winters H, Tielemans H, Paulus V, Hummelink S, Slater N, Ulrich D . A systematic review and meta-analysis of vascularized lymph node transfer for breast cancer-related lymphedema. J Vasc Surg Venous Lymphat Disord. 2021; 10(3):786-795.e1. DOI: 10.1016/j.jvsv.2021.08.023. View

2.
Basta M, Gao L, Wu L . Operative treatment of peripheral lymphedema: a systematic meta-analysis of the efficacy and safety of lymphovenous microsurgery and tissue transplantation. Plast Reconstr Surg. 2013; 133(4):905-913. DOI: 10.1097/PRS.0000000000000010. View

3.
Verhey E, Kandi L, Lee Y, Morris B, Casey W, Rebecca A . Outcomes of Lymphovenous Anastomosis for Lower Extremity Lymphedema: A Systematic Review. Plast Reconstr Surg Glob Open. 2022; 10(10):e4529. PMC: 9542573. DOI: 10.1097/GOX.0000000000004529. View

4.
Donahue P, MacKenzie A, Filipovic A, Koelmeyer L . Advances in the prevention and treatment of breast cancer-related lymphedema. Breast Cancer Res Treat. 2023; 200(1):1-14. PMC: 10224871. DOI: 10.1007/s10549-023-06947-7. View

5.
Torgbenu E, Luckett T, Buhagiar M, Phillips J . Guidelines Relevant to Diagnosis, Assessment, and Management of Lymphedema: A Systematic Review. Adv Wound Care (New Rochelle). 2022; 12(1):15-27. DOI: 10.1089/wound.2021.0149. View